Amina Hosaini Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 60 Miller Farms Rd, Willington, CT 06279 Phone: 860-768-3435 |
News Archive
PATIENTS with long-term conditions such as mental health disorders, chronic obstructive pulmonary disease, diabetes and stroke are set to benefit from a major multi-million pound partnership between the region's NHS organisations, leading universities, local government, industry, charities, patients and the public.
Tiltan Pharma Ltd. today announced that it has enrolled the first U.S. patient, at White Plains Hospital in Westchester County N.Y., in a Phase 2 clinical trial of its anti-angiogenic product, TL-118, for the treatment of metastatic pancreatic cancer.
A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School, USA, and Karolinska Institutet, Sweden, presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.
Biomedical engineers at Johns Hopkins have developed a new liquid material that in early experiments in rats and humans shows promise in restoring damaged soft tissue relatively safely and durably.
A new study has shown that allowing "dark play" in a serious video game intended to practice skills transferable to a real-life setting does not impact the game's effectiveness.
› Verified 2 days ago